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Abstract
Background and hypothesis: The high sensitivity of hematopoietic cells, especially stem cells, to radiation and to pro-
oxidative and other leukemogenic agents is related to certain of their morphological and metabolic features. It is
attributable to the low (minimal) number of active mitochondria and the consequently slow utilization of O2 entering the
cell. This results in an increased intracellular partial pressure of O2 (pO2) and increased levels of reactive oxygen (ROS)
and nitrogen (RNS) species, and a Δ(PO – AO) imbalance between the pro-oxidative (PO) and antioxidative (AO)
constituents.
Proposed mechanism: Because excessive O2 is toxic, we suggest that hematopoietic cells exist in a kind of unstable
dynamic balance. This suggestion is based on the idea that mitochondria not only consume O2 in the process of ATP
production but also constitute the main anti-oxygenic stage in the cell's protective antioxidative system. Variations in the
mitochondrial base capacity (quantity and quality of mitochondria) constitute an important and highly efficient channel
for regulating the oxidative stress level within a cell.
The primary target for leukemogenic agents is the few mitochondria within the hematopoietic stem cell. Disturbance and
weakening of their respiratory function further enhances the initial pro-oxidative state of the cell. This readily results in
peroxygenation stress, creating the necessary condition for inducing leukemogenesis. We propose that this is the main
cause of all related genetic and other disorders in the cell. ROS, RNS and peroxides act as signal molecules affecting
redox-sensitive transcription factors, enzymes, oncogenes and other effectors. Thereby, they influence the expression
and suppression of many genes, as well as the course and direction of proliferation, differentiation, leukemogenesis and
apoptosis.
Differentiation of leukemic cells is blocked at the precursor stage. While the transformation of non-hematopoietic cells
into tumor cells starts during proliferation, hematopoietic cells become leukemic at one of the interim stages in
differentiation, and differentiation does not continue beyond that point. Proliferation is switched to differentiation and
back according to a trigger principle, again involving ROS and RNS. When the leukemogenic ΔL(PO – AO) imbalance
decreases in an under-differentiated leukemia cell to the differentiation level ΔD(PO – AO), the cell may continue to
differentiate to the terminal stage.
Conclusion: The argument described in this article is used to explain the causes of congenital and children's leukemia,
and the induction of leukemia by certain agents (vitamin K3, benzene, etc.). Specific research is required to validate the
proposals made in this article. This will require accurate and accessible methods for measuring and assessing oxidative
stress in different types of cells in general, and in hematopoietic cells in particular, in their different functional states.
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Background
According to the general oxygen-peroxide concept of car-
cinogenesis, the primary targets for damage by carcino-
genic agents and factors are mitochondria [1]. They
consume up to 95–99% of the free oxygen (O2) that
enters the cell, which is known to be toxic in excess. In this
sense, mitochondria perform an anti-oxygen function and
constitute the main stage in the protective hierarchical
antioxidative system of the cell. This system obviously
arose during the course of evolution as organisms adapted
to the gradually increasing O2  content of the earth's
atmosphere. This antioxidative function of mitochondria
is usually omitted from accounts or simply ignored by
investigators, who emphasize the main role of these
organelles as ATP generators.
Any failure of mitochondrial activity must decrease the
amount of O2 they utilize and consequently increase the
partial pressure of O2 (pO2), i.e. cause intracellular hyper-
oxia. This induces a proportional increase in the forma-
tion of reactive oxygen (ROS) and nitrogen (RNS) species,
and in the peroxygenation of different intracellular con-
stituents and structures. These changes are aggravated if
both the quantity and quality (i.e. activity) of mitochon-
dria decline. Such disturbances are precisely those
observed in neoplastic cells. The argument of the present
paper hinges on this major question: why and how does
peroxygenation stress, the negative consequences of
which have long been well-known, occur in cells? Those
consequences have been described in many publications,
not only those devoted to carcinogenesis [1].
Thus, both the presence of mitochondria and changes in
their quantitative-qualitative parameters constitute an
important mode of regulation of the oxygen-peroxide
state (peroxygenation stress) and the signaling pathways
that depend on it. Considering that mitochondria as
dynamic structures are subject to fusion and fission,
which alter the mitochondrial base "capacity", this chan-
nel of regulation becomes especially efficient [2].
In developing this argument, we first propose the follow-
ing hypothesis. During the course of evolution, a
sequence of "specialized" ranges of intracellular Δ(PO –
AO) imbalances has been established between pro-oxida-
tive (PO) and antioxidative (AO) constituents as a way of
adapting to increasing oxygen-peroxide levels. Each range
became associated with a particular complex biochemical
process, perhaps necessarily so. A specific consequence is
that several ranges of Δ(PO – AO) imbalance can be gen-
erated during the postnatal ontogenesis period. These
ranges are distinguished by the particular PO and AO val-
ues established under defined conditions; the precise cell
state attained corresponds to and/or depends on these val-
ues. Within the limits of the ΔP(PO – AO) and ΔC(PO –
AO) imbalance ranges, proliferation (oxidative mitogene-
sis of a normal non-tumor cell) and carcinogenesis pre-
dominate, respectively. At the ΔCy(PO – AO) imbalance,
cytolysis occurs; and within the ΔA1(PO – AO) and
ΔA2(PO – AO) imbalance ranges, apoptosis of the A1 and
A2 types ensue, respectively. These phenomena mirror
evolutionary origins and are seemingly paradoxical: apop-
tosis of tumor cells is induced by both antioxidants (A1
type) and prooxidants (A2 type) [1,3]. By "range of imbal-
ance" we mean all possible values (not a single value)
within the limits of the range. In their abbreviated forms,
these "specialized" imbalances are presented as the fol-
lowing sequence:
ΔP < ΔA1 < ΔC < ΔA2 < ΔCy (a)
Aging of cells most probably occurs within the ΔAg(PO –
AO) imbalance range, which lies between the ΔP and ΔA1
imbalances. When this range is added, sequence (a)
appears as follows:
ΔP < ΔAg < ΔA1 < ΔC < ΔA2 < ΔCy (b)
By evaluating and considering the inequalities summa-
rized in (b), we have formulated general propositions
about the oxygen-peroxide concept of development,
aging, age-related pathologies, carcinogenesis and pro-
grammed cell death [1,3]. Mitochondria occupy a central
place in the sequence of inequalities since they are critical
for the life and death of a cell.
Given the PO and AO constituents of all the imbalances
described above, we identify certain integral "pro-quanti-
tative" indicators: steady-state (bound) levels of prooxi-
dants and antioxidants, and/or their production rates at
the time that they participate in the induction of prolifer-
ation, aging, carcinogenesis or apoptosis.
The development of leukemia induced by radiation or
other leukemogenic agents is known to be related to the
malignant systemic hematopoietic tissue disease, dyshe-
matopoiesis. This pathology is manifest in the prolifera-
tion of immature pathological cell elements; it has various
types, distinguished by the predominance of different ele-
ments. The most widely recognized kind arises when most
of the real target cells are pluripotent stem hematopoietic
cells (PSHC) and the precursors of different blood cell
lines. It is not yet known why these cells are particularly
sensitive to different leukemogenic factors; opinions
about this matter differ.
A preliminary attempt [4] to use the abovementioned
"oxygen-peroxide" concept to understand the mechanism
of leukemogenesis seemed reasonable but raised ques-
tions. Why and how does such a state occur in PSHC?Theoretical Biology and Medical Modelling 2008, 5:23 http://www.tbiomed.com/content/5/1/23
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These questions refer to issues of principle. Of course, it
will be desirable to find answers consistent with the "oxy-
gen-peroxide" hypothesis of leukemogenesis. It would be
natural to suppose that the mechanism by which neoplas-
tic hematopoietic stem cells are transformed into leuke-
mia cells has features generally similar to, and not
fundamentally different from, the malignant transforma-
tions of non-hematopoietic cells. The leukemogenesis lit-
erature that we have been able to access shows that there
really are significant similarities, but at the same time
there are important differences. Some of our ideas about
this are described below. Before returning to this topic,
however, we will elaborate the general reasoning in sup-
port of our proposal in the hope of attracting scientific
attention to it.
Oxygen-peroxide effects and the mechanism of 
leukemogenesis
The "oxygen-peroxide" concept of leukemogenesis is
based on the following assumption. PSHC and erythro-
cyte precursors contain the minimally required number of
mitochondria, sufficient only to support a stable ΔP(PO –
AO) imbalance within them, and undergo practically
unlimited proliferation (oxidative mitogenesis). This
opinion is confirmed only in single publications. Thus,
the authors of [5] demonstrated that the low levels of
mitochondrial respiratory chain components in hemat-
opoietic stem cells correlate with the low O2 consumption
by them. Therefore, such cells must be relatively hyper-
oxic, and distinctively hypersensitive to radiation and
other insults that aggravate the oxygen-peroxide situation.
According to our understanding, the required (minimal)
number of mitochondria in specialized cell types is natu-
rally adjusted to utilize intracellular O2 in order to effect
certain basic, non-energetic functions that are also useful
for the cell, including synthetic functions. But for this very
reason, such cells exist in a state of unstable dynamic bal-
ance. Even with an insignificant negative disturbance,
mitochondrial respiration readily elevates the Δ(PO –
AO) imbalance to pathological levels. In particular, PSHC
face an enhanced risk of disease, leaving the normal
hematopoiesis pathway, when the normal ΔP(PO – AO)
imbalance rises to the leukemogenic level ΔL(PO – AO);
this is similar in essence (in terms of values and evoked
consequences) to the "carcinogenetic" imbalance ΔC(PO
– AO) in non-hematopoietic cells. At ΔL(PO – AO) in
PSHC both epigenetic and genotypic abnormalities are
more probable (see figure 1). For this major reason, the
frequency of e.g. spontaneous leucosis increases. Thus, a
study of AKR mice revealed an increased frequency and
speed of development of leucosis under the influence of
small and ultra-small doses of radiation (1.2–2.4 cGy)
[6].
The finding that mitochondria are subject to significant
negative changes during leucosis transformation in PSHC
and bone marrow hemato- and lympho-poiesis precursor
cells agrees with our assumption. For instance, according
to well-established information [7,8], these changes are
mainly qualitative in patients with acute lymphoblast
leukemia (ALL) and acute myeloid leukemia (AML), and
consist in the following: the number of irregular-shaped
mitochondria grows, the mitochondrial matrix and mem-
branes are damaged, cristae are disorganized, etc. By these
indicators, leucosis cells do not differ from neoplastic cells
of other types. Other authors have reported similar find-
ings. For example, neoplastic cells in AML patients have
mitochondria that vary in size and form and show
reduced numbers of cristae. These common ultrastruc-
tural changes correlate with abnormal metabolic func-
tions such as impaired intra-mitochondrial protein
synthesis [9]. ALL patients have more disorganized mito-
chondria than AML patients; the degree of mitochondrial
disorder is greater in patients with bad prognoses [10]. It
should be noted that our hypothesis – that the oxygen-
peroxide aspect of mitochondria is involved in leukemo-
genesis – was not considered in the publications cited
here, so our proposals on this matter are novel.
A striking feature of leucosis is the bimodal age distribu-
tion of its frequency: it primarily affects patients older
than 55 years and children under 10 [11]. To date, there
has been no satisfactory explanation for the enhanced risk
of leucosis in young children. We suggest that in some
children the hematopoietic tissue cells and immature
hemocytes (blood cells) have excessive Δ(PO – AO)
imbalances. This is most likely to be connected to a mito-
chondrial base insufficiency or mitochondrial deficiency
and may have a genetic cause. Individuals who possess
such defects must be more predisposed to leukemogene-
sis, and children in this category become vulnerable to
leukemia. Spontaneously, or under the influence of even
small doses of prooxidative agents, particularly radiation,
leukemia can develop comparatively easily in them.
The same approach may contribute to understanding of
the similarly unexplained phenomenon of congenital
leukemia. Here, the problem is probably related to the fact
that pre-leucosis changes occur in some cases during the
prenatal ontogenesis period. These changes develop into
the clinical forms of leucosis under the influence of cer-
tain postnatal factors [12]. Briefly, our version of this con-
cept is as follows. The low levels of respiratory chain
components in PSHC mitochondria correlates, as men-
tioned above, with weak O2 consumption [5]. This feature
is apparently also characteristic of the precursors of vari-
ous blood cell lines. Therefore, increased levels of pO2 and
peroxygenation stress are imposed on all these cells by the
weak mitochondrial capacity. In these different cell lines,Theoretical Biology and Medical Modelling 2008, 5:23 http://www.tbiomed.com/content/5/1/23
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Structure functional block diagram of mitochondrial (oxygen-peroxide) concept of leukemogenesis Figure 1
Structure functional block diagram of mitochondrial (oxygen-peroxide) concept of leukemogenesis. IL – induc-
ers of leukemogenesis; for other designations see text.
Low number of mitochondria (main consumers of free intracellular oxygen) in PSHC 
(initial premise of our hypothesis).
Low number of mitochondria entails weak utilization of O2, so initially there is a slight 
increase of intracellular oxygen level (condition of weak hyperoxia). 
High sensitivity of cells especially towards radiation, pro-oxidative and other negative 
influences (condition of unstable dynamic balance).
Further increase of Ɉ2-dependent levels of ROS, RNS and peroxides and ¨ (PO – AO) 
imbalance in PSHC caused by leukemogenic inductors, especially antimitochonndrial 
(condition of peroxygenase stress).
IL
Activation of the redox-sensitive transcription 
factors, enzymes, oncogenes and other effectors 
by ROS and RNS as signal molecules (present in 
excess) and by peroxides. 
Modification of sensitive genome elements by 
excess ROS, RNS and peroxides. 
Changes in the gene expression pattern and the 
course and direction of fundamental, synthetic 
and regulatory processes (proliferation, 
differentiation, apoptosis etc.). 
Translocations, point mutations and other 
genome alterations in PSHC, generally as 
events secondary to the primary oxygen-
peroxide agents. 
Epigenetic and genotypic disorders, leading to the 
characteristics of leukemogenesis.Theoretical Biology and Medical Modelling 2008, 5:23 http://www.tbiomed.com/content/5/1/23
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which are quite heterogeneous in composition, this leads
to an immediate increase of the normal "proliferative"
imbalance ΔP(PO – AO) to the ΔL(PO – AO) level required
for leukemogenesis. Within this imbalance range, ROS
and peroxide products may modify many intracellular
structures, including DNA. It is probably for this reason
that chromosome translocations characteristic of chil-
dren's leucosis are already apparent during normal embry-
onic development, producing latent leucosis clones [12].
In old age, leucosis apparently develops for the same prin-
cipal reasons, the only difference being that mitochon-
drial deficiency and sporadic mutations of mitochondrial
DNA in hematopoietic cells are extended in time in the
course of ontogenesis and accumulate slowly, acting
simultaneously as the aging factor [1].
Other features of the incidence of leucosis in new-born
children after administration of vitamin K as an anti-hem-
orrhagic factor are also of interest. This topic is discussed
in [13], which presents the arguments of those who deny
that vitamin K is implicated in the induction of leucosis.
In our view, a crucial point is that the group K vitamins,
specifically vitamin K3 (menadion), are able to cause oxi-
dative stress in cells [14]. In PSHC and blood cell line pre-
cursors, the prooxidative action of these vitamins should
be leukemogenic, in accordance with the oxygen-peroxide
concept discussed in this paper. The lack of unambiguous
results after vitamin K treatment may be attributable to
other conditions of which no account has been taken; this
point requires additional research.
Among of the observations supporting the oxygen-perox-
ide mechanism of leukemogenesis, we should also men-
tion the so-called "benzene" leucosis, which ultimately
proves to be ROS-inducible. According to the data in [15],
phenolic metabolites of benzene enter the bone marrow
and are converted to semiquinone radicals and quinones.
ROS formed from these derivatives affect tubulins, his-
tones, topoisomerase II and other proteins linked to DNA,
and DNA itself. Since carcinogenic phenolic metabolites
of benzene (phenol, hydroquinone, catechol, etc.) are
widespread in the environment, they could cause "spon-
taneous" leucosis in a human by a mechanism such as
that described here. However, in this variant of "chemical
leucosis", a peroxidase-carcinogenesis status is also cre-
ated in the bone marrow cells. This results from the inac-
tivation by benzene metabolites of respiratory enzymes
and mitochondrial DNA. The latter is known to be quite
sensitive to chemical carcinogens [16].
The above-described bioenergetic features of PSHC and
blood cell line precursors suggest that such a mechanism
for the induction of leukemogenesis, involving hemat-
opoietic cells affected by agents in the microenvironment,
is plausible. The proposal concerns reticular cells forming
reticular tissue, which in turn constitutes the basis of
hematopoietic organs. The reticulo-endothelial cells have
high phagocytic capacity. In the presence of agents such as
colony-stimulating factors, reticular cells can turn into
active macrophages. In this role, they produce ROS and
are obviously readily capable of increasing the ΔP(PO –
AO) imbalance in adjacent (and already comparatively
hyperoxic) hematopoietic cells to the leukemogenic level,
ΔL(PO – AO). In other words, realization of the oxygen-
peroxide mechanism of leukemogenesis by macrophages
of the hematopoietic organ itself is quite probable. This
inference is consistent with our view [17] of the "macro-
phagous" mechanism of carcinogenesis induced by for-
eign bodies.
Other consequences of excessive peroxygenation in 
leukemia cells
The lipid peroxide (LPO) level in leukemogenesis is sig-
nificantly enhanced because of direct free-radical oxida-
tion of lipids, which is made likely by a weak
mitochondrial capacity and therefore incipient intracellu-
lar hyperoxia. In addition, there is an abnormally high
density of blood vessels in the bone marrow of patients
with acute myeloleukemia or lympholeukemia or with
chronic myeloleukemia [18]. Neovascularization is
another facet of the oxygen-peroxide mechanism of leuke-
mogenesis. However, judging from the data in the litera-
ture, a significant part of the excessive LPO in leukemia
cells is also produced by lipid peroxidation processes that
are normal parts of the mitogenic cascade. This is clearly
apparent when these processes and the effects dependent
on them are suppressed.
In this respect, the facts appear to demonstrate that 5-
lipoxygenase (5-LOX) inhibitors exert a powerful anti-
proliferative action on malignant human hematopoietic
cell lines. Thus, while specific lipoxygenase metabolites of
arachidonic acid – B4 and D4 leukotrienes – stimulate pro-
liferation of the malignant lines -562, EM-2, HL-60 and U-
937, a specific 5-LOX inhibitor, Piriprost, causes a revers-
ible 95% inhibition of such proliferation [19]. Activators
of 5-LOX, specifically peroxides of fatty acids, increase the
tendency of these cells to transform because they reliably
enhance the "leukemogenic" ΔL(PO – AO) imbalance in
them. According to radioimmunoassay data [20], there is
increased expression of cyclooxygenase-2 (COX-2) in
patients in the chronic stage of chronic myeloblastosis.
This increased expression is associated with a low survival
rate. These facts are also mostly accounted for by our pro-
posed mechanism: either COX-2 or LOX, participating in
arachidonic acid oxidation and ROS formation, contrib-
utes to increasing the oxidative stress level in cells. Conse-
quently, COX-2 can serve as an enzymatic basis for the
negative "leukemogenic" values of ΔL(PO – AO).Theoretical Biology and Medical Modelling 2008, 5:23 http://www.tbiomed.com/content/5/1/23
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Excessive peroxygenation processes are also toxic to intra-
nuclear structures and leukemia cell functions. The targets
for ROS and LPO products are DNA and nuclear proteins,
particularly non-histone proteins. For example, in chil-
dren with ALL, changes in basic nitrogens typically
induced by hydroxyl radicals are identified in lymphocyte
DNA [21]. In this context, it is particularly interesting that
there is a statistically greater frequency of p53 anti-onco-
gene mutations in hematological than non-hematological
neoplasms. According to one account, the difference may
be related to the absence of hypoxia in most hematologi-
cal neoplasms [22]. We do not reject that explanation, but
suggest that it can be made more specific by invoking the
ROS dependence of p53 mutation. A number of publica-
tions [23,24] have reported that mutation of the p53 gene
in some non-hematological tumor cells is actually caused
by oxidative stress. Such stress is likely to be more marked
in malignant hematological cells, particularly leukemia
cells, in view of their mitochondrial-energetic features.
This should make p53 gene mutations more frequent
under ΔL(PO – AO) than under ΔC(PO – AO) conditions.
Moreover, enhanced peroxygenation conditions could
also explain the occurrence of multiple significant
changes within the nuclear genome during leukemogene-
sis. The following phenomena are most frequently
observed: different translocations of genetic elements,
deletions, point mutations, etc. We think it important to
stress our alternative "non-genetic" opinion: these genetic
changes do not serve in toto as the original cause of leuke-
mogenesis; on the contrary, they are mainly secondary to
the effects of primary DNA-modifying agents. As we have
said, the latter include excessive ROS, RNS and some per-
oxides [1,25] formed under the influence of different
agents and factors, specifically leukemogenic ones.
Hematopoietic cells are particularly sensitive to such
effects from the outset because of their mitochondrial-
energetic features (see above). This is precisely why
prooxidant agents lead comparatively easily, directly or
indirectly, to negative rearrangements of the nuclear
genome in such cells.
The oxygen-peroxide concept of leukemogenesis explains
many features of the protective actions of various antioxi-
dants. Among the latter, we draw particular attention to
resveratrol, a phenol antioxidant that is a natural compo-
nent of grape skins. Depending on the dose, resveratrol
suppresses the growth of THP-1 human monocytic leuke-
mia cells [26]. It also displays anti-leukemia activity with
respect to mouse (L1210) and human (U937, HL-60) leu-
cosis cells, suppressing their proliferation. Furthermore,
resveratrol inhibits the proliferation of normal hemat-
opoietic precursor cells, but this effect is partially reversi-
ble while its action on leukemia cells is irreversible [27].
Resveratrol is not only an anti-leukemia agent but also a
universal anti-carcinogenic agent. This indirectly supports
the view that these processes are rooted in the general oxy-
gen-peroxide mechanism we have proposed.
2-chloro-2'-deoxyadenosine has been promoted as an
efficient new anti-leucosis drug. Its characteristic feature is
its early action on mitochondrial functions and mito-
chondrial DNA content, as shown within ≤ 7 days in cul-
tured CCRF human leukemia cells [28]. Intracellular lactic
acid formation was used in that study to trace changes in
oxidative phosphorylation and mitochondrial dysfunc-
tion. A brief incubation with 2-chloro-2'-deoxyadenosine
increased the amount of lactate after a 12-hour exposure,
in parallel with cytotoxicity. From our point of view, these
results are attributable to an increase in the Δ(PO – AO)
imbalance from the leukemogenic level to the A2 apopto-
sis level, or immediately to cytolysis, primarily caused by
reduced mitochondrial respiration and hyperoxia inside
the leukemia cells aggravating the shifts already present.
Basically the same effects should be caused by any other
agent and factor that enhances oxidative stress in leuke-
mia cells. Among such factors are apparently those that
induce apoptosis in HL-60 [29] and U-937 [30] cells. In
contrast, reduction of the ΔL(PO – AO) imbalance in these
cells should lead to A1 apoptosis. A possible example is
illustrated in [31].
The proposed mitochondrial concept of leukemogenesis
is summarized in the block diagram (figure 1).
Differentiation of leukemia cells: problem analysis and 
suggestions
Another aspect of the topic under discussion still remains
difficult to understand: the connection between the proc-
esses causing leukemogenesis and the differentiation of
hematopoietic cells during early development. The fact
that this differentiation process is often enhanced during
leucosis transformation testifies to the existence of such a
connection [32]. It would seem that in the course of nor-
mal differentiation, just as in case of non-hematopoietic
cells, energy requirements should lead towards the devel-
opment of increased numbers of well-differentiated mito-
chondria [2,33], and this should effectively increase the
intensity of mitochondrial respiration and concomitantly
reduce the intracellular ΔP(PO – AO) imbalance and POL
level. The latter is needed for normal oxidative mitogene-
sis in immature cellular elements of the hematopoietic
system.
However, events may develop in other directions during
the differentiation of hematopoietic and leukemia cells.
This is implied by the following major difference: most
types of neoplasm lose control over their own fission, but
in the case of leucosis, differentiation undergoes "block-
age" or "arrest" – or just stops – at the precursor cell stageTheoretical Biology and Medical Modelling 2008, 5:23 http://www.tbiomed.com/content/5/1/23
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[34,35]. To the prevailing consensus, the retention of the
expressed differentiated state in hemoblastosis appears
mysterious and even illogical.
On the basis of this significant difference, we can try to
understand certain "oddities" in the behavior of the
under-differentiated leukemia cells under the influence of
various agents, especially those that stimulate the prolifer-
ation of normal non-hematopoietic cells. One "oddity" is
that leukemia cells to a certain extent preserve the sensitiv-
ity towards regulatory mechanisms that are characteristic
of normal cells. This allows the possibility of inducing dif-
ferentiation in leukemia cells: a cell in which differentia-
tion has been stopped can subsequently resume the
process, up to the terminal stage, under the influence of
various agents [35-37].
Most surprising, according to numerous data in the litera-
ture [38-40], is the ability of leukemia cells to differentiate
under the influence of phorbol ethers. These compounds
serve as growth stimulators and tumor promoters for the
majority of normal non-hematopoietic cells. Through cer-
tain isoforms of protein kinase C (PKC), they launch the
cycle of phosphatidylinositide, lipo- and cyclooxygenase
signal pathways, which activate proliferation, with ROS
increasing the formation of oxidized metabolites of ara-
chidonic acid. This leads to an increased Δ(PO – AO)
imbalance, generating a condition required for cell prolif-
eration but not differentiation. Why then is an inverse pic-
ture observed in the leukemia cell lines HL-60, -562, U-
937 and others when they are exposed to the above-men-
tioned promoters, i.e. when the differentiating phenotype
is induced? There is still no exact answer to this question;
our views might be of some interest in this apparently
contradictory situation.
Let us start from the following statement. The transfer to a
"carcinogenous" ΔC(PO – AO) imbalance in non-hemat-
opoietic cells is most likely to start during the prolifera-
tion stage, i.e. from the state that is commonly considered
a prerequisite for tumor transformation. In hematopoietic
cells, increase of the ΔC(PO – AO) imbalance to the ΔL(PO
– AO) leukemogenic level frequently (but not always)
begins directly during one of the early stages of differenti-
ation. We consider this moment to be of primary impor-
tance. Differentiation is a multistage process, alternating
with cell division. Many changes occur at each stage in
transcription and translation, implementing a particular
part of the differentiation program and creating the pre-
conditions required for progression to the succeeding
stage.
Mitochondria are again variously involved in the prolifer-
ation and differentiation of hematopoietic cells. They are
quite dynamic structures, subject to regular fusion and fis-
sion during both biogenesis and its antithesis, disintegra-
tion, and at different stages of cell development. These
processes inevitably change with the total capacity and
activity of the mitochondria. In PSHC, which have few
mitochondria, the processes in question probably occur
on a limited scale. A well-known regularity is observed: an
increased concentration of mitochondrial material is a
prerequisite for the shift of balance from proliferation to
differentiation [33,41].
During mitochondriogenesis, because O2 consumption
grows, intracellular levels of pO2 and of the ROS and RNS
signal molecules fall markedly and the ΔP(PO – AO)
imbalance decreases to the range ΔD(PO – AO) required
for differentiation of "specialized" functions. When these
parameters change in such a way, transcription factors
that depend on them are activated and the genes required
for PSHC differentiation are expressed. Another opinion
on this point is expressed by the authors of [5]. They sup-
pose that NAD(P)H-oxidase is involved in hematopoietic
stem cell differentiation. Fulfilling the role of free O2 sen-
sor, this enzyme produces ROS, which as signal molecules
induce the expression of genes needed for mitochondrio-
genesis, to which differentiation of these cells is linked.
From the point of view of our "oxygen-peroxide"
approach, this differentiation is again determined by
reduction of the ΔP(PO – AO) imbalance at mitochondri-
ogenesis in proliferating PSHC to the differentiating level
ΔD(PO – AO). Subsequently, the same authors [42] dem-
onstrated another phenomenon. Some catalytic subunits
of the NADPH oxidase family, and all isoforms of its reg-
ulatory subunits, are expressed at the mRNA and protein
levels in hematopoietic stem cells. These results may be
interpreted in terms of fine adjustments of the ROS level,
produced constituently, via positive feedback. This makes
redox-mediated regulation of growth and differentiation
possible in these stem cells.
All the events during mitochondrial degradation and
destabilization develop in the opposite direction. Because
O2 utilization falls in such mitochondria, pO2 rises, ROS
and RNS concentrations are increased, and the ΔD(PO –
AO) imbalance increases again to ΔP(PO – AO). Nor-
mally, these processes alternate until the hematopoietic
cells reach terminal differentiation. Unfortunately, details
of the triggering mechanism that regulates the interrela-
tionship between proliferation and differentiation are still
not clear. The events occurring here can develop, for
instance, under the following scheme. At some intermedi-
ate stage of hematopoietic cell differentiation, when the
ΔD(PO – AO) imbalance changes to the ΔP(PO – AO)
range, active spontaneous change or the effects induced by
pro-leukemogenic agents and factors starts. These further
reduce the capacity and/or activity of the mitochondrial
base. One may be involved in suppressing the set ofTheoretical Biology and Medical Modelling 2008, 5:23 http://www.tbiomed.com/content/5/1/23
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nuclear genes that encode components of the mitochon-
drial protein complexes. Therefore, the ΔD(PO – AO)
imbalance can immediately – bypassing the ΔA1(PO –
AO) range – increase to the leukemogenic level ΔL(PO –
AO), and the hematopoietic cell state is transformed
towards uncontrolled proliferation. As at the ΔP(PO –
AO) imbalance, this blocks differentiation at the stage of
the  under-differentiated  precursor cell according to the
non-antagonistic trigger principle. Such an effect is possi-
ble given the availability of genes "tuned" by a reversible
trigger to fix the cell in one of two possible states. In the
first state, leukemogenic proliferation at ΔL(PO – AO)
interrupts differentiation. In the second, in contrast, dif-
ferentiation at the ΔD(PO – AO) imbalance interrupts pro-
liferation. This switch is performed under the influence of
agents and factors that initially change the levels of
prooxidants and antioxidants. The intervals between the
"specialized" ranges of imbalances in hematopoietic cells
are apparently insignificant. Therefore, transfers from one
range to another occur comparatively easily, even with rel-
atively small changes in the PO- and AO- constituents of
the Δ(PO – AO) imbalance.
The gene HOX11 has interested us in this respect. Accord-
ing to the data described in [43], HOX11 is regarded as the
gene causing leucosis. It is able to immortalize hemat-
opoietic cell lines and is clinically associated with acute T-
cell lymphoblastic leukemia in children. It has also been
shown that enhanced HOX11 expression changes the
erythroid differentiation of J2E cells towards the forma-
tion of less mature precursor cells. On the basis of these
facts, the authors of this investigation [43] drew the fol-
lowing conclusion: disturbance of hematopoietic cell dif-
ferentiation is responsible for the pre-leucosis
immortalization of cells by HOX11 oncoprotein. These
data could in our view be interpreted in another way. Spe-
cifically, we suspect that the HOX11 oncogene somehow
– directly or indirectly – produces a prooxidant action.
Therefore, the PO/AO imbalance in a cell with such an
active oncogene increases to the leukemogenic level
ΔL(PO – AO). The signal molecules corresponding to this
proliferative level, including ROS, RNS and some perox-
ides, then induce the trigger mechanism of switching. This
interrupts the process of differentiation that occurred
before the cell was transferred into a leukemogenic state
by the ΔD(PO – AO) imbalance. In the situation
described, the effect on leukemia cells of factors that in
some way lower the ΔL imbalance can lead to A1 apopto-
sis. A publication devoted to the induction of apoptosis in
P388 lympholeucosis cells could serve as an example here
[44]. A more marked reduction of the ΔL imbalance to the
ΔD value should remove the differentiation blockade and
differentiation should continue. In contrast, the effect on
leukemia cells of agents and factors that enhance intracel-
lular oxidative processes leads, in our view, to A2 apopto-
sis; for example, of HeLa and U-937 cells (see above).
Returning to the differentiating potential of phorbol
ethers, we suggest the following. According to old infor-
mation [45,46], these ethers, by activating PKC, enhance
the phosphorylation of adenylate cyclase system compo-
nents. This action increases the sensitivity and activity of
adenylate cyclase, which is known to be low in leukemia
cells. Further events within a leukemia cell may, according
to our proposal, develop in the following sequence:
increase in the cyclic adenosine monophosphate (cAMP)
content → stimulation of cAMP-activity of mitochondria
respiratory enzymes [47] → increased O2 consumption by
these (relatively few) organelles → reduction of intracellu-
lar O2 and of the ΔL(PO – AO) imbalance to the differen-
tiating level ΔD(PO – AO). The correspondingly reduced
levels of the signal molecules, ROS and RNS, induce the
activity of certain transcription factors and the expression
of genes that depend on them, including genes required
for differentiation.
The transfer proliferation → differentiation should obvi-
ously be accompanied by the suppression of most of the
cell cycle control genes, and on the other hand by the
expression of genes that inhibit this cycle. In particular,
specific cyclin-dependent kinase inhibitors are expressed
in the G1  phase, and these reprogram leukemia cells
towards terminal differentiation [48]. The same regula-
tory mechanism may contribute to the production of
endogenous bioregulatory myelopeptides, which can
induce the terminal differentiation of HL-60 and -562
cells and also stimulate in vitro differentiation of bone
marrow cells in AML patients [49]. A sufficient mass of
new information has been collected on the participation
of different ROS and RNS as signal molecules in the
simultaneous positive and negative regulation of expres-
sion of hundreds of genes, including oncogenes [50,51].
The foregoing reasoning about the differentiation of
leukemia cells also applies to some non-hematopoietic
tumor cells. They are also known to be differentiated,
though in fewer cases.
Overall, taking into account the normal exchange
between proliferative and differentiating imbalances, ΔP
↔ ΔD, the "specialized" imbalances Δ(PO – AO) applied
to the transformation and differentiation of hematopoi-
etic cells are presumably linked by inequalities (see figure
2)
In the form presented here, the oxygen-peroxide concept
of leukemogenesis cannot reasonably explain the facts
described in the literature on the differentiation of leuke-
mia cells under prooxygenase effects. For example, differ-Theoretical Biology and Medical Modelling 2008, 5:23 http://www.tbiomed.com/content/5/1/23
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entiation of leukemia cells is induced by dimethyl
sulfoxide, tetradecanoyl phorbol-acetate (TPA) and dibu-
tyryl-cAMP by increasing ROS formation. These data do
not quite fit the scheme we present.
Conclusion
We have related our discussion of the oxygen-peroxide
mechanism of leukemogenesis to the fundamental fact
that there are only a few mitochondria in PSHC, the pre-
cursors of the various blood cell lines. The very existence
of mitochondria, the main consumers of O2 entering the
cells, allows us to regard these ATP-producing organelles
as the major anti-oxygen stage in the cell's protective anti-
oxidative system. Variation of the mitochondrial base
capacity (quantity and quality of mitochondria) is consid-
ered an important and particularly effective channel for
regulating the oxidative stress level within a cell. The ideas
used in the present article are centered on the adaptive
emergence of a sequence of "specialized" ranges of Δ(PO
– AO) imbalance during the course of evolution and the
fixation of these ranges in cells. Each entails the possibility
and even necessity of a implementing a definite complex
biochemical process.
The principal important effects arise from the minimiza-
tion of the mitochondrial content of hematopoietic stem
cells. Taken together, they result in hematopoietic stem
cells becoming objects at high risk of spontaneous or
induced transformation into leukemia cells via the oxy-
gen-peroxide mechanism (figure 1). The anti-leucosis
actions of various antioxidants (resveratrol etc.) support
the view that leucosis proceeds in accordance with this
Expected transfers of "specialized" imbalances in the hematopoietic cells under the influence of inducers of leukemogenesis and  differentiation Figure 2
Expected transfers of "specialized" imbalances in the hematopoietic cells under the influence of inducers of leukemogenesis and 
differentiation
IL - inducers of leukemogenesis 
ID – inducers of differentiation 
DT – terminal differentiation Theoretical Biology and Medical Modelling 2008, 5:23 http://www.tbiomed.com/content/5/1/23
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mechanism. The reasoning presented in this article leads
to inferences about the causes of congenital and children's
leucosis, and several facts about leucosis being induced by
definite agents (vitamin K3, benzene, etc.) are interpreted
in a new way.
The capacity of leukemia cell differentiation to be blocked
at the precursor cell stage still remains mysterious. Accord-
ing to our version, the transformation of normal non-
hematopoietic cells into tumor cells begins during the
proliferation stage. But normal hematopoietic cells are
transferred to the leucosis state by the effects of leuke-
mogenic agents and factors starting from one of the inter-
mediate stages in differentiation, and they stop at that
stage. In the presence of appropriate stimuli, the under-
differentiated leukemia cell can continue to differentiate
to its terminal stage.
Normally, the switch from proliferation to differentiation
and back occurs under the trigger principle. The Δ(PO –
AO) imbalances corresponding to these two processes are
involved in this switching; for normal cells, ΔD < ΔP, and
for leucosis cells, ΔD < ΔL. The agents (antioxidants, etc.)
that lower the ΔL imbalance in a leukemia cell to the ΔA1
value or directly to ΔD induce type A1 apoptosis or differ-
entiation respectively. An increase in the ΔL imbalance to
the ΔA2 level leads to A2 type apoptosis in a leukemia cell
(see inequalities c and d). In all cases, the direct and/or
indirect participants in the switches are ROS, RNS, some
peroxides and "specialized" Δ(PO – AO) imbalances cor-
responding to their levels.
To validate the hypothesis discussed here, specific
research directions are required. Success depends on the
development of precise and accessible methods for meas-
uring and assessing the oxidative stress level in various cell
types in general, and hematopoietic cells in particular, in
their different functional states.
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